Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy Test And Treat topic
No spam. Unsubscribe anytime.
Senate caucus advances pharmacist 'test-and-treat' bill amid debate over access and over-medication
Summary
Senate Health and Human Services summaries described SB 12 14, which would permit pharmacists to independently test and treat certain conditions under statewide protocols; supporters said it improves access, especially in rural areas, while some members warned it could increase unnecessary medication use.
Senate staff described Senate Bill 12 14 to the caucus as a measure that would permit pharmacists to independently test and treat eligible patients for specified conditions and direct the Arizona State Board of Pharmacy to develop a statewide written protocol for that authority.
Why it matters: Supporters told the caucus the bill would expand timely access to care where physician availability is limited, particularly in rural Arizona. Critics expressed concern that lowering barriers could lead to overuse of medications or increase unnecessary medicalization.
As amended in committee, SB 12 14 creates an independent testing-and-treatment authority for pharmacists, establishes an advisory committee to help write statewide protocols, and places responsibility on the Board of Pharmacy to formalize the rules. Staff said the bill was on the third-read consent calendar.
Chair members argued the change addresses access gaps: recorded remarks from the chair described pharmacists' testing equipment and protocols as comparable to those used in physician offices and said the policy is intended to “give patients an option if they so choose to seek treatment at a pharmacy.” Supporters emphasized the value of timely testing to detect conditions such as strep throat and begin treatment sooner.
Opponents said the measure raises behavioral and public-health trade-offs. Representative Webb told the caucus she is concerned about broader societal consequences if testing access prompts a large increase in visits and prescriptions for minor ailments, saying the change could encourage “everybody [to] go for everything.” Another member asked whether pharmacists would be allowed to prescribe medication after testing; staff and the chair summarized the bill’s intent as allowing pharmacists to test and treat under the written protocols developed by the Board of Pharmacy.
The bill was placed on the third-read consent calendar; no final floor vote was recorded in the caucus transcript. Staff agreed to follow up on protocol details and any outstanding operational questions members had about prescribing and scope.
